Skip to main content
. 2020 Sep 29;12(10):2985. doi: 10.3390/nu12102985

Table 11.

RCTs examining the effect of dietary patterns on serum PSA concentrations among men with PCa or increased PCa risk.

First Author Origin Masking Duration Patients Interventions Results
Hébert [206] US Open-label 6 mo n = 54 men with a confirmed PCa, treated by prostatectomy, or radiation therapy 1. Diet (low meat and dairy, increased intake of whole grains, soybeans and by-products, other beans, and vegetables), PA (45-min sessions), and stress reduction sessions (n = 29)
2. Usual treatment (n = 25)
No difference in Δ PSA was noted by intervention status. Men increasing their fruit intake experienced no PSA rise.
Demark-Wahnefried [208] US Single-blind until prostatectomy (30.7 d) n = 161 scheduled at least 21-d before prostatectomy 1. Usual diet (n = 41)
2. Flaxseed-supplemented diet (30 g/d) (n = 40)
3. LFD (<20% fat) (n = 40)
4. Flaxseed-supplemented (30 g/d) LFD (<20% fat) (n = 40)
Over the presurgical study period serum PSA decreased in all arms, with no differences in change observed between arms.
Ornish [210] US NR 1 yr n = 98 men with early, biopsy-proven PCa after 1 yr, PSA 4–10 ng/mL and Gleason score ≤ 7 1. Intensive lifestyle program promoting a vegan diet, supplemented with soy (1 serv of tofu + 58 g fortified soy PRO drink), fish oil (3 g/d), vitamin E (400 IU/d), Se (200 μg/d), and vitamin C (2 g/d), moderate aerobic PE (walking 30 min, 6 d/wk), stress management (yoga-based stretching, breathing, meditation, imagery, relaxation for a 60 min/d), and 1-h support group once weekly to enhance adherence to the intervention. Diet: fruits, vegetables, whole grains (complex CHO), legumes, and soy products, low in simple CHO and with 10% fat (n = 44)
2. Usual diet (n = 49)
Changes in serum PSA from baseline to 12 mo were different between groups, with favorable changes in the experimental group. Serum PSA decreased (0.25 ng/mL, or 4%) from baseline in the treatment arm, but increased in the control group.
Kellogg Parsons [211] US Single-blind 2 yr n = 443 men (50–80 yrs) with biopsy-proven PCa 1. Counseling behavioral intervention by phone promoting the intake of ≥7 vegetable serv/d (n = 226)
2. Written information about diet and PCa (n = 217)
There were no significant differences in TTP between groups.
Aronson [212] US Single-blind 4–6 wks n = 55 patients undergoing radical prostatectomy 1. Western diet (40% fat, 15% PRO, 45% CHO, 15 g fiber/d, n-6:n-3 FA ratio of 15:1) (n = 26)
2. LFFO diet (15% fat, 15% PRO, 70% CHO), 39 g fiber/d and 5 × 1.1 g fish oil caps/d (200 mg EPA, 367 mg DHA) with a ratio of n-6:n-3 FA to 2:1 (n = 26)
No differences were noted in the PSA concentrations of participants in the two groups.
Aronson [213] US NR 4 wks n = 18 men with PCa who did not receive prior therapy 1. High-fiber LFD (15% fat, 30% PRO, 55% CHO), 35 g soy PRO/d, and 35 g fiber/d) (n = 9)
2. Western diet (40% fat, 30% PRO, no soy, 30% CHO, 10 g fiber/d) (n = 9)
No differences were observed in the PSA concentrations.
Antwi [142] US NR 6 mo n = 54 men with a history of PCa and rising PSA concentrations post-prostatectomy/radiation 1. Dietary modifications, PA, and mindfulness-based stress reduction training, including shopping guidelines (n = 29)
2. Standard care (n = 25)
No differences were observed in the PSA concentrations between participating groups.
Tariq [223] CA NR 4 mo n = 14 healthy men with hyperlipidemia 1. Diet high in soluble fiber (approx. 25–30 g fiber/1000 kcal, ≤20% fat, ≤20% PRO, ≥60% CHO) (n = 9)
2. Diet high in insoluble fiber (approx. 25–30 g fiber/1000 kcal, ≤20% fat, ≤20% PRO, ≥60% CHO) (n = 5)
Serum PSA concentration was lower with the soluble than the insoluble fiber diet.
Freedland [217] US NR 6 mo n = 42 patients with PCa initiating ADT 1. LCD (≤20g CHO/d) plus walking (≥30 min for ≥5 d/wk)
2. Usual diet and exercise patterns
No differences were observed in the PSA concentrations.
Freedland [218] US NR 6 mo n = 34 men with PCa and BCR after local treatment 1. LCD (≤20g CHO/d) (n = 14)
2. Usual diet (n = 20)
PSA values did not differ between groups. The proportion of patients with slowed PSADT was greater in the LCD arm.
Li [219] US NR 4 yr n = 40 men post-prostatectomy, at high risk for recurrence 1. LFD (15% fat), high-fiber (18 g/1000 kcal) diet supplemented with 40 g soy PRO + individual counseling sessions (n = 26)
2. USDA recommended diet (n = 14)
No significant changes in PSA were reported between groups.
Carmody [220] US NR 3 mo n = 24 men previously treated for PCa and their partners 1. 11 dietary and cooking classes (emphasizing plant-based foods and fish -salmon-, vegetables-, cruciferous varieties-, and whole grains, as well as soy foods, with avoidance of meat, poultry, and dairy) (n = 10)
2. Control group (n = 14)
No change was found in the rate of PSA increase between the two groups; the mean PSADT for the intervention participants was substantially longer.
Shike [221] US NR 2 yrs n = 1230 men with normal DRE results, PSA concentrations < 3 ng/mL 1. Intensive counseling towards an LFD, high in fiber, fruits, and vegetables (n = 627)
2. Standard brochure on a healthy diet (n = 603)
No difference was observed in the distributions of the PSA slopes, the PSA slopes per se, or the % of high PSA concentrations between groups. The incidence of PCa at 4 yrs was similar.
Eastham Š [222] US Open-label 4 yrs n = 1197 men 1. LFD high in fiber, fruits, and vegetables (n = 611)
2. Usual diet (n = 586)
No difference was noted in serum PSA concentrations by dietary intervention.

ADT, androgen deprivation therapy; ALA, alpha-linolenic acid; AS, active surveillance; BCR, biochemical recurrence; CI, confidence intervals; CHO, carbohydrates; CoQ10, coenzyme Q10; DHA, docosahexaenoic acid; DRE, digital rectal examination; EPA, eicosapentaenoic acid; FA, Fatty acids; GLA, γ-linolenic acid; LCD, Low-carbohydrate diet; LFD, Low-fat diet; LFFO, low fat/fish oil; NR, not reported; NS, not significant; PCa, prostate cancer; PE, physical exercise; PRO, proteins; PSA, prostate-specific antigen; PSADT, prostate-specific antigen doubling time; RCT, randomized controlled trials; TEI, total energy intake; TTP, time to progression (PSA ≥ 10 ng/mL); USDA, United States Department of Agriculture. phase II trial; cross-over trial; Š post-hoc analysis.